Proto Labs, Inc. carries a market capitalization of 1.78B, placing it among publicly traded companies globally. Its enterprise value stands at 1.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.78B |
| Enterprise Value | 1.23B |
Proto Labs, Inc. currently has 23.79M shares outstanding.
| Shares Outstanding | 23.79M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Proto Labs, Inc. trades at a trailing price-to-earnings ratio of 52.76. The price-to-sales ratio is 2.49, and the price-to-book ratio stands at 5.46.
| PE Ratio | 52.76 |
| PS Ratio | 2.49 |
| PB Ratio | 5.46 |
| P/TBV Ratio | 3.47 |
| P/FCF Ratio | 15.19 |
| P/OCF Ratio | 18.45 |
On an enterprise value basis, Proto Labs, Inc. trades at an EV/EBITDA multiple of 18.52 and an EV/FCF ratio of 13.49. The EV/Sales ratio of 2.24 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 37.16 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.24 |
| EV / EBITDA | 18.52 |
| EV / EBIT | 37.16 |
| EV / FCF | 13.49 |
Proto Labs, Inc. maintains a current ratio of 3.51, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.51 |
| Quick Ratio | 3.15 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 0.04 |
| Interest Coverage | N/A |
Proto Labs, Inc. posts a return on equity of 10.61 and a return on invested capital of 3.48.
| Return on Equity (ROE) | 10.61 |
| Return on Assets (ROA) | 3.40 |
| Return on Invested Capital (ROIC) | 3.48 |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 21.46 |
Over the trailing twelve months, Proto Labs, Inc. has paid 10.64M in income taxes, reflecting an effective tax rate of 29.24.
| Income Tax | 10.64M |
| Effective Tax Rate | 29.24 |
Proto Labs, Inc.'s stock has gained approximately 98.80192% over the past 52 weeks. The 50-day moving average sits at 65.56, while the 200-day moving average is 56.39.
| Beta (5Y) | N/A |
| 52-Week Price Change | 98.80192% |
| 50-Day Moving Average | 65.56 |
| 200-Day Moving Average | 56.39 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Proto Labs, Inc. generated 546.26M in revenue and converted that into 25.75M in net income, yielding earnings per share of 1.06. EBITDA reached 66.16M, while operating income came in at 32.97M.
| Revenue | 546.26M |
| Gross Profit | 245.03M |
| Operating Income | 32.97M |
| Pretax Income | 36.39M |
| Net Income | 25.75M |
| EBITDA | 66.16M |
| EBIT | 32.97M |
| Earnings Per Share (EPS) | 1.06 |
Proto Labs, Inc. holds 136.28M in cash and equivalents against 2.62M in total debt, resulting in a net debt position of -123.97M. Total book value stands at 248.90M, with working capital of 177.86M providing operational flexibility.
| Cash & Cash Equivalents | 136.28M |
| Total Debt | 2.62M |
| Net Debt | -123.97M |
| Equity (Book Value) | 248.90M |
| Book Value Per Share | 10.45 |
| Working Capital | 177.86M |
Proto Labs, Inc. produced 73.66M in operating cash flow over the past twelve months. After subtracting -17.12M in capital expenditures, free cash flow totaled 56.54M - equivalent to 2.37 per share.
| Operating Cash Flow | 73.66M |
| Capital Expenditures | -17.12M |
| Free Cash Flow | 56.54M |
| FCF Per Share | 2.37 |
Proto Labs, Inc. operates with a gross margin of 44.86, reflecting its pricing power and cost economics. The operating margin of 6.04 and net profit margin of 4.71 provide insight into operational efficiency.
| Gross Margin | 44.86 |
| Operating Margin | 6.04 |
| Pretax Margin | 6.66 |
| Profit Margin | 4.71 |
| EBITDA Margin | 12.11 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 1.31 |
| FCF Yield | 6.58 |
Proto Labs, Inc. posts an Altman Z-Score of 11.04, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 11.04 |